Inventiva S.A. IVA
We take great care to ensure that the data presented and summarized in this overview for Inventiva S.A. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding IVA
View all-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$5.85 Million0.25% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$3.23 Million0.21% of portfolio
-
Bvf Inc San Francisco, CA686KShares$1.52 Million0.04% of portfolio
-
Commonwealth Equity Services, LLC39.7KShares$87,8140.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA16.3KShares$36,0820.0% of portfolio
-
Morgan Stanley New York, NY1.4KShares$3,0940.0% of portfolio
-
Covestor LTD Boston, MA337Shares$7440.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
Latest Institutional Activity in IVA
Top Purchases
Top Sells
About IVA
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.
Insider Transactions at IVA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|